Drugs.com - Pharma Industry News

Obinutuzumab Efficacious for Renal Response in Lupus Nephritis

WEDNESDAY, Feb. 26, 2025 -- For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone...

Feb 26, 2025 - 18:25
 0
Obinutuzumab Efficacious for Renal Response in Lupus Nephritis
WEDNESDAY, Feb. 26, 2025 -- For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone...
Read More

Tags:

Previous Article

Study IDs Factors Linked to Risk for Transfer From Peritoneal Dialysis to Hemodi...

Next Article

Children With Obesity Have Increased Rates of Dermatologic Conditions

Related Posts

IgG-Guided Elimination Diet Beneficial for Irritable Bowel Syndrome

IgG-Guided Elimination Diet Beneficial for Irritable Bo...

Feb 20, 2025  0

ACP Issues Clinical Guideline for Pharmacologic Prevention of Episodic Migraine

ACP Issues Clinical Guideline for Pharmacologic Prevent...

Feb 10, 2025  0

Daily Screen Time Tied to Higher Myopia Risk

Daily Screen Time Tied to Higher Myopia Risk

Feb 25, 2025  0